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ABSTRACT – As the recent outbreaks in Edinburgh and 
Camarthen, UK, have shown, Legionella pneumonia (LP) 
remains a significant public health problem, which is not only 
confined to those who have travelled abroad. In both out-
breaks and sporadic cases, diagnosis can go unrecognised. We 
reviewed the demographics, comorbidities, diagnosis, treat-
ment and clinical outcome of LP cases over five years in a dis-
trict general hospital in northwest England. Over half of LP 
cases were UK acquired and ‘classic’ clinical features were 
common. Clinical criteria for diagnosing LP were confirmed, but 
few sputum samples were sent to reference laboratories, lim-
iting further essential epidemiological mapping of UK cases. 
Following current UK community-acquired pneumonia guid-
ance would have missed nearly one quarter of LP cases in our 
series, potentially leading to further morbidity and mortality.
KEY WORDS: descriptive; atypical; Legionella; pneumonia; 
CURB-65; outcome
Introduction
Specific guidance on the investigation and early diagnosis of 
Legionella pneumonia (LP) is limited despite this infection com-
prising nearly 7% of all community-acquired pneumonias (CAP) 
in some series1 and up to 13% of pneumonias dealt with in outpa-
tient settings.2 Rates of LP are increasing3 and it continues to cause 
high morbidity and mortality.4 Recent LP outbreaks, such as those 
in southwest Edinburgh and Camarthen, have been associated with 
acquisition of infection within the UK and are a stark reminder of 
the severity of the disease. UK Health Protection Agency (HPA) 
data have shown that, over the past 31 years (1980–2011), just over 
half of UK LP cases were associated with recent travel, mainly over-
seas.5 However, a travel history alone has little predictive value. 
Moreover, although presentation can include ‘classic’ features of 
atypical pneumonia, these features are not sufficient to accurately 
differentiate LP from pneumonia of other aetiology.6
Rapid testing for LP using Legionella urinary antigen (LUA) is 
now widely available and reporting of positive results to local 
public health authorities is not only recommended but is also a 
legal requirement.6 The CURB-65 score7 enables severity assess-
ment and can help optimise antibiotic therapy.
In 2011, in a report from the Cumbria and Lancashire Health 
Protection Unit of the HPA to the Department of Microbiology of 
Blackpool Teaching Hospitals, an uneven distribution of LP was 
noted in the Cumbria and Lancashire region, with clustering of 
44% of total cases in the Blackpool area between 2001 and 2009 
(Fig 1). This clustering did not appear to be either a UK-acquired 
community outbreak or related to the location of registered wet 
cooling systems (also known as industrial water coolants; Fig 2). 
When compared with other trusts serving similar-sized popula-
tions in the north west region, no increased frequency of LUA 
testing was found in Blackpool Teaching Hospitals that could have 
accounted for the apparent clustering of cases (Fig 3).
An observational, descriptive, retrospective analysis of all LP 
cases over the preceding five years was undertaken to examine 
the apparent clustering of cases in north-west England.
Methods
In total, 26 LP cases with a positive LUA test (BinaxNOW, Inverness 
Medical, UK) were identified from the pathology database of the 
Blackpool Teaching Hospitals between July 2006 and July 2011. 
This time period was chosen because microbiological reporting 
was standardised to the computerised pathology database from 
2006 onwards.
 Case-note review was undertaken to gather specific data on 
demographics, comorbidities, foreign travel history, clinical and 
microbiological findings, diagnosis, treatment and clinical out-
come (Table 1). In addition, information on dates of symptom 
onset and delay before admission was collated from HPA data.
Statistical analysis involved comparisons of means using 
unpaired t-test for parametric data and Mann-Whitney U test 
for nonparametric data. Additional simple univariate logistic 
regression was performed using the STATA program (version 
12).
Results
Demographics, history, comorbidity, duration of symptoms 
before admission and diagnosis, clinical findings, microbio-
logical findings and outcome are summarised in Table 2.
Demographics
Of the patients, 20/26 (77%) were men, with a mean age of 66 years 
(median 66, range 41–87). Women had a higher mean age than 
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men, but this was not significant (women 72 years, 95% 
confidence interval (CI) 60–87 vs men 63 years, 95% CI 
57–68, p0.1). 
Of those that acquired LP in the UK, all residences 
were defined as ‘own home’ and no clustering was 
found between these postcodes.
Over half of the patients were current smokers, 14/26 
(54%). Of those patients with documented data avail-
able, over two-thirds drank alcohol, 16/23 (70%), with 
over one third being moderate–heavy drinkers (alcohol 
unit intake >30 units per week).
Comorbidity
Three of the 26 patients (12%) were immunosup-
pressed: two patients were taking long-term steroids 
>15 mg daily and another patient with severe rheuma-
toid arthritis was taking adalimumab (an antitumour 
necrosis factor agent) and weekly methotrexate. In 
addition, four of the 26 patients (15%) had existing 
chronic kidney injury (CKI), with one of these patients 
being on regular dialysis before admission. Six of the 26 
patients (23%) had diabetes. 
Foreign travel
In total, 12/26 (46%) patients reported foreign travel 
within the previous month: 10/12 within Europe, with 
Italy and Spain being the most commonly visited des-
tinations. Two patients had travelled beyond Europe 
(Fig 4).
Clinical and microbiological findings
In total, 96% (25/26) of patients had consolidation 
on chest X-ray: this was unilateral in 22/25 patients 
(88%) and bilateral in 3/25 (12%) patients. No patients 
had radiographic evidence of pleural effusions or 
pneumonitis. 
Initial CURB-65 score was not documented in 15/26 
patients (58%). Of the documented initial CURB-65 
scores, the median was 3 (5/11, range 0–4). For those 
without a documented initial CURB-65 score, their score 
was subsequently calculated by the investigators using 
clinical documentation, blood results and physiological 
observations from case notes (see Discussion). 
Of the 26 patients, 22 (85%) had new liver derange-
ment, mainly hepatitic with an isolated increase in aspar-
tate transaminase (AST).
Mean serum sodium (Na) at diagnosis was 129.9 
mmol/l (range 122–136), with 23/26 patients (88%) 
showing some degree of biochemical hyponatraemia. In 
addition, 9/26 (35%) of the patients had new-onset 
confusion or other neurological features. Mean serum 
Na in those with neurological features was 128.1 mmol/l 
Fig 1. Geographical distribution of Legionella cases in northwest England, 2001–
2009. Dark blue squares represent travel-associated cases, light blue squares 
represent community-acquired cases. © Crown copyright and database rights 2012, 
Ordnance Survey, 100016969.
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Fig 2. Geographical distribution of wet cooling systems in northwest England, 
2001–2009. © Crown copyright and database rights 2012, Ordnance Survey, 
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Outcome
The median length of stay (LOS) was five days (range 4–119, 
mean 18 days). Of the 26 patients, 15 (58%) were treated on a 
specific respiratory medicine ward. In addition, 7/26 (27%) of 
the patients required care in a high dependency (HDU) or inten-
sive treatment (ITU) unit. Of the 26 patients, six (23%) died, five 
of whom died within the first five days of admission. Two of 
these patients died on ITU, one on HDU, and the remaining two 
on respiratory wards. 
Those who died during admission were significantly older than 
those who survived to discharge (79 years (95% CI 70–88) vs 
60 years (95% CI 55–66), p<0.001). Of those who died, five (83%) 
had UK community-acquired LP. The demographics of patients 
who died are shown in Table 3.
Of those surviving to discharge, 3/20 (15%) were readmitted 
within three months, all for unrelated medical conditions.
On univariate logistic regression analysis of the effect of demo-
graphic and clinical variables on outcome, only lower age was 
associated with a decreased likelihood of death (OR 0.83 (95% CI 
0.72–0.97), p<0.02). There was a tendency towards lower CURB-65 
(n=9) and 131.7 mmol/l in those without neurological features 
(n=17); however, this trend was not statistically significant 
(p=0.09).
Diagnosis and treatment
Patients had a mean of four days between symptom onset and 
admission to hospital (range 0–14 days). LUA was identified a 
mean two days into admission (range 0–6 days), with results being 
phoned by laboratory scientists to the ward directly in all cases. The 
full time and date of the result given by telephone was documented 
in notes from 23/26 (88%) patients. The mean total number of 
days between symptom onset and diagnosis was six (range 1–15).  
Antibiotic prescriptions in 6/26 patients (23%) did not conform 
to local or national guidance, with these patients receiving addi-
tional antibiotic groups or broader spectrum antibiotic cover than 
recommended at lower CURB-65 scores (data not shown). Of 
those who survived until discharge, 20/20 (100%) received appro-
priate antibiotic cover for LP (defined as 10–14 days of appropriate 
dose, route and choice of macrolide or quinolone). Antibiotic regi-
mens after LP diagnosis are shown in Fig 5.
Table 1. Data collection proforma and definitions
Data collected Definition and explanation of collected data
Demographics 
and/or relevant 
history
• Age (at time of presentation) and gender
• Postcode and type of residency: own home, residential and/or nursing home
• Smoking history: defined as current smoker yes or no
• Alcohol intake: 21–30 units defined as moderate, >30 units high
• Foreign travel to include destination and length of stay
Comorbidities •  Immunosuppression: defined as primary immunodeficiency disorder or secondary disorder owing to HIV or medication including 
prednisolone >15 mg/day or other immunosuppressive agents
•  Other severe chronic illness, including liver, lung and kidney disease: defined as disease requiring input from a secondary care 
specialist (ie consultant in renal, respiratory or gastroenterology medicine)
•  Diagnosis of diabetes (data were not collected on duration or type of diabetes, recent diabetes control or type of diabetes treatment)
Clinical and 
microbiological 
findings 
•  New neurological dysfunction or encephalopathy (any neurological presentation, such as nerve palsies, confusion or 
sensorineural deficit)
• Chest radiograph findings: none, unilateral consolidation, bilateral consolidation, pleural effusions or pneumonitis
• Documentation of CURB-65 score by admitting physician
• Recalculated CURB-65 score based on clinical documentation and physiological observations in case notes
•  New liver derangement: data on peak aspartate transaminase levels, alkaline phosphatase levels and bilirubin taken using local 
normal ranges as standard, previous results examined if available
• Presence of new hyponatraemia on admission: using local normal range as standard, 135–145 mmol/l
•  New AKI: defined as creatinine newly higher than local normal range or deterioration in baseline estimated glomerular filtration rate
Diagnosis and 
treatment 
•  Time elapsed between admission and positive LP result being alerted to the ward (based on documentation in notes of the time 
at which the result was phoned through to the appropriate ward to be actioned)
• Other Legionella tests sent (sputum culture and serology)
• Confirmatory tests sent to reference laboratory
• Antibiotic choices initially (and whether they conformed to local and national guidelines relating to CURB-65 score)
• Antibiotic choices after LP diagnosis confirmed
• Duration of antibiotic therapy
• Ward on which patient was cared for
•  Maximum level of care required during admission (level 1 care  ward based being, level 2 care  high dependency unit (HDU), 
level 3 care  intensive therapy unit (ITU))
Outcome • Length of stay (LOS)
• Death (including number of days into admission)
• Readmission within three months of discharge
AKI  acute kidney injury; HIV  human immunodeficiency virus; LP  Legionella pneumonia.
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scores (0–2) being associated with decreased likelihood of death, 
but this did not reach statistical significance (OR 0.18 (95% CI 
0.23–1.33), p=0.09). No other demographic or clinical factors were 
predictive of outcome, including days from symptom onset to 
admission and diagnosis (Table 4). Subsequently, no multiple 
logistic regression analysis was performed.
Discussion
After being alerted by the HPA that, between 2001 and 2009, 
there appeared to be an uneven distribution of the LP cases in 
the Lancashire and Cumbria region, with 44% being in the 
Blackpool area, we undertook an observational, descriptive, ret-
rospective analysis of all LP cases in our trust, Blackpool 
Teaching Hospitals, between July 2006 and July 2011.
LP was first reported after an outbreak at an American Legion 
conference in 19768 and, since then, the number of LP cases in 
high-resource settings has continued to increase.9 Legionella 
pneumophila comprises 90% of Legionellaceae family infec-
tions,10 with L. pneumophila serogroup 1 being most common.11 
Legionella spp. are heat-stable bacteria that have been associated 
with colonisation of sources as varied as wet cooling systems, 
pollution-relieving aerosols,3 asphalt-paving machines,12 spa 
pools,13 showers, fountains and even windscreen-wiper fluid 
containers.14 
With LP being the cause of up to 7% of CAP and hospital-
acquired pneumonias (HAP),1 and with mortality in outbreaks 
being as high as 20%,4 the disease continues to pose a significant 
public health risk. A recent outbreak of LP in southwest Edinburgh 
resulted in high levels of morbidity and three deaths, while a cur-
rent outbreak in Camarthen, South Wales remains under investiga-
tion (www.bbc.co.uk/news/uk-wales-19654519).
The proportion of patients with LP requiring care in HDU 
or ITU facilities is significant. Nearly one-fifth of CAP cases in 
ITU were related to LP in some series, higher than was found in 
those with CAP but not admitted to ITU.15,16 However, with early 
recognition and appropriate treatment, it is estimated that mor-
tality can be reduced to below 5%.17–19
Patients with LP are more likely to be male20 and smokers,21 a 
trend that was followed in our cohort (77% male, 54% smokers). 
Although Legionella is known to affect any age group,22 the mean 
average age in our series was 65 years, with affected women being 
older than men. 
 Little evidence exists as to the effect of comorbidities on either 
acquisition or severity of LP. British23 and Spanish24 studies have 
demonstrated chronic illness and worsening kidney function to be 
associated with poorer outcome, as is chronic lung disease. There is 
little evidence for the severity of LP in immunosuppressed patients, 
although one study following up patients with systemic lupus ery-
thematosus taking infliximab reported a death secondary to LP.25 
However, only a small number in our series were im-munosup-
pressed or had chronic kidney disease.
Over two-thirds of our cohort drank alcohol, 38% of whom 
were moderate to heavy drinkers. Alcoholism has previously been 
recognised as a predictor of more severe disease.24 
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Fig 4. Destination of those patients with a relevant travel history 
(n12).
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Fig 5. Choice of antibiotic for Legionella cover after diagnosis (n=26). 
Sputum samples were collected for reference laboratory confirmation 
in 5/26 patients (19%). 
Fig 3. Number of Legionella urinary antigen (LUA) tests per regional 
hospital. Regional hospitals A (dark blue line) and B (light blue line) serve 
populations of a similar size to Blackpool Victoria Hospital (grey line). 
Data courtesy of the Cumbria and Lancashire Health Protection Unit.
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patients travelling further afield. Conversely, an interesting 
finding from our series was that 54% of patients had UK-acquired 
LP, none of whom had any relevant ‘within-UK’ travel history. 
This number is similar to that previously demonstrated in UK 
public health data. However, in contrast to these previous data, 
which had suggested that fewer than 10% of cases were related to 
travel inside the UK, none of the patients with UK-acquired LP 
in our series reported such travel.30 This is likely to be biased by 
lack of documentation in clinical notes. 
Recent evidence suggests that wider availability of LUA test has 
led to increased diagnosis of nosocomial LP that might otherwise 
have gone unnoticed;31 however, all patients in the current series 
had confirmed CAP. No postcode clustering was found in 
UK-acquired cases to account for a geographically linked pattern of 
LP acquisition or transmission (data not shown). In addition, after 
liaison with local environmental health department officers, who 
reviewed previous Legionella sources and their updated register of 
wet cooling systems, neither did the Cumbria and Lancashire 
Health Protection Unit find any associated geographical clustering 
of wet cooling systems in the region. However, It was acknowledged 
that it was unlikely that all wet cooling systems would be registered 
with the appropriate authorities for analysis. Other potential expla-
nations, such as local weather patterns, were not examined within 
the confines of this study, and the HPA remains vigilant to new LP 
cases and continues to monitor the local situation.
A variety of well-recognised clinical and biochemical features 
are suggestive of LP, including fever, gastrointestinal disturbance, 
confusion, meningoencephalitis, new neurological features (such 
as nerve palsies, including Guillain–Barré syndrome), deranged 
liver function tests, hyponatraemia and kidney failure.8,32–34 
Many of our cohort had a combination of these ‘classic’ features, 
indicating that they continue to be relevant in clinical assess-
ment: 88% had biochemical hyponatraemia; 54% had AKI, as 
shown in other series;33 85% had hepatitis liver derangement 
(only 7% showed a cholestatic picture); and 35% had new-onset 
confusion or other neurological features. Although there was a 
trend in our series towards lower mean average serum Na in 
those patients presenting with neurological features than those 
without, this did not reach statistical significance. 
Of note for the clinician, two patients with LP and neurolog-
ical features presented with marked cerebellar syndrome, an 
uncommon but recognised presentation.35 
 LUA testing is rapid, highly specific and recommended as a 
first-line diagnostic test for early Legionella diagnosis.36 However, 
LUAs only identify L. pneumophila Serogroup 1 and have mod-
erate overall sensitivity (74% in a recent meta-analysis),37 which 
improves with greater disease severity.18 The mean average of 
two days until a positive LUA result in our study is likely to 
reflect ward-based delay in requesting the test, rather than a lab-
based delay in reporting the result; however, it was not possible 
to verify this from analysis of patients’ case notes. Although on 
regression analysis no association between outcome and time 
from symptom onset to admission or diagnosis was found, this 
is likely to be related to the size of our patient cohort being too 
small to identify any possible effect.
In our study, 23% of patients had diabetes, which is higher than 
the 4.88% background local rate.26 The apparent LP–diabetes asso-
ciation is biologically plausible, because diabetes impairs immune 
function27 and has been linked with increasing susceptibility to 
other infections, such as tuberculosis.28 However, it is more likely 
within our series that this association is confounded by age.
In patients with LP in the UK, infection is often associated with 
a travel history abroad (commonly to southern Europe).29 Nearly 
half (46%) of our cohort had undergone foreign travel within the 
previous month (Fig 4), mostly within Europe, but with two 
Table 2. Demographics, comorbidities, foreign travel history and 
clinical and/or microbiological findings.
Patient demographics (n26) Number (% or range)
General demographics and social history
Mean age (years) 66 (41–87)
Male sex 20 (77%)
Active smoker 14 (54%)
Drink alcohol 16 (70%)
Comorbidities
Immunosuppressed 3 (12%)
Chronic kidney disease 4 (15%)
Diabetes 6 (23%)
Duration of symptoms and time to diagnosis
Days from symptom onset to admission 4 (0–14)
Days from admission to diagnosis 2 (0–6)
Total days from symptom onset to diagnosis 6 (1–15)
Foreign travel
No foreign travel 14 (54%)
Foreign travel in Europe 10 (42%)
Foreign travel outside of Europe 2 (4%)
Clinical and microbiological findings
Consolidation on chest X-ray 25 (96%)
No CURB-65 score documented 15 (58%)
New liver derangement 22 (85%)
New hyponatraemia 23 (88%)
New neurological features 9 (35%)
Acute kidney injury (AKI) 14 (54%)
Initial CAP treatment according to recognised 
guidelines
20 (77%)
LP treatment according to recognised 
guidelines
26 (100%)
Outcome
Median length of stay (days) 5 (4–119)
Required HDU and/or ITU care 7 (27%)
Died 6 (23%)
CAP  community-acquired pneumonia; ITU  intensive treatment unit; HDU  
high dependency unit.
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Table 3. Demographic data for those patients who died during 
admission (n=6).
Category Demographic Patients with 
Legionella pneumonia 
who died (n6)
Demographic Age (mean years) 78.8
Sex (male) 5
Travel history Yes, foreign or other travel 
before admission
1
Smoker Yes, active smoker 4
Comorbidity Chronic kidney injury (CKI) 2
Severe liver disease 0
Severe lung disease 1
of unrelated cases is higher. The patients who died were older than 
the cohort average (79 vs 65 years, p=0.017), half had severe 
chronic illness and two-thirds were ongoing smokers. The differ-
ence in mortality rates between our cohort and those of outbreaks 
may relate to heightened clinical suspicion during outbreaks.
This study has several limitations. First, it describes a patient 
group of limited numbers, enabling only minimal statistical 
analysis. Second, its retrospective design means that it is reliant on 
data collection from documentation in clinical case notes. Finally, 
no comparison was made with demographic, clinical and out-
come data of patients with non-Legionella pneumonias within the 
same study setting.
Most patients (25/26, 96%) had consolidation on chest X-ray: 
in 22/25 patients (88%), this was unilateral, a propensity that has 
been noted in other studies.38 
Despite wide recognition in the UK of the CURB-65 score and 
its incorporation into both local and national CAP guidelines, 
admission CURB-65 score was not documented in over half of the 
patients. Furthermore, the antibiotic prescription was inappro-
priate for the severity of disease (as per documented CURB-65 
score) in 23% of patients. Of particular note, a significant propor-
tion of patients had a recalculated CURB-65 score of 0–2 (62%). 
Table 5 shows the demographics of this subgroup. Of these 
patients, who had either risk factors for, or travel history suggestive 
of, LP, 77% received appropriate Legionella cover. However, 23% of 
these patients with a CURB-65 score <2 had neither relevant travel 
history nor any documented evidence of high clinical Legionella 
suspicion, but still went on to have a LUA test sent and began treat-
ment with antibiotics that included cover against Legionella (a 
macrolide in all cases). It is unclear whether the choice of mac-
rolide in these cases was the result of suspicion of ‘atypical’ pneu-
monia, but it is clear that strict adherence to national CURB-65 
guidance in these patients with low CURB-65 scores would have 
meant not testing or treating for atypical pneumonias, including 
Legionella. Current UK guidance recommends Legionella testing in 
‘severe’ pneumonia (CURB-65 3), when there is high clinical 
suspicion, or during outbreaks.6 There was no known acute out-
break of Legionella locally at this time and so guidance would have 
missed nearly one-quarter (6/26) of Legionella cases in our series. 
It may be postulated that, despite their low CURB-65 scores, these 
patients had other clinical features that made the ‘clinical suspicion’ 
for potential Legionella diagnosis high (eg failure to respond to 
first-line beta-lactam or aminoglycoside antibiotics in the com-
munity, profound hyponatraemia, deranged liver function tests, 
neurological signs or multisystem involvement). However, it was 
not possible to elicit this subjective ‘clinical suspicion’ from the 
patient case notes with any certainty.
Of those who survived until discharge, 20/20 (100%) received 
appropriate Legionella therapy as documented in Fig 5, and all of 
these patients had microbiology clinician involvement. 
Full typing and resistance profiling of both the urine and sputum 
samples of LP patients at reference laboratories is recommended. 
However, sputum testing occurred in only 19% of our cases. LP 
remains a significant public health problem and acquisition of 
quality epidemiological data will require the vigilance of physicians 
to send further confirmatory tests that might not be of direct ben-
efit to the patient but of benefit to the wider community. This issue 
could be brought to the clinician’s attention on reports of a positive 
diagnosis or through phone calls from the microbiology depart-
ment to the patient’s attending physician.
Overall morbidity and mortality were high, with nearly one-
third of patients requiring HDU or ITU care. Median LOS in those 
treated on HDU or ITU was 31 days, as opposed to five days if 
managed on a ward. Nearly one-quarter of the patients died, 
mostly early into admission, with five of the deaths being within 
the first five days. Although data from outbreak studies have shown 
mortality rates of up to 20%,4 the mortality rate seen in our cohort 
Table 4. Simple univariate logistic regression of the effect of 
demographic and clinical variables on outcome of survival to 
discharge in patients with Legionella pneumonia.
Variable Odds 
ratio
Standard 
error
P value 95% CI
Age 0.83 0.06 <0.02 0.72–0.97
Male sex 0.6 0.73 0.673 0.56–6.44
Smoker 0.75 0.73 0.8 0.11–5.11
Alcohol drinker 3.25 3.24 0.3 0.46–22.90
Diabetic 1.67 2.02 0.7 0.16–17.90
Known chronic kidney 
injury (CKI)
0.22 0.25 0.2 0.02–2.10
Relevant travel history 6.11 7.24 0.1 0.6–62.2
Neurological features 1.08 1.06 0.9 0.2–7.4
Newly deranged liver 
function tests
4.5 5.14 0.2 0.5–42.3
CURB-65 <3 0.18 0.18 0.09 0.2–1.3
Days from symptom 
onset to admission
0.98  0.15 0.9 0.7–1.3
Days from admission to 
diagnosis
0.85 0.26 0.6 0.5–1.6
Total days from symptom 
onset to diagnosis
0.94 0.14 0.7 0.7–1.3
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Conclusions
In our study, over half of Legionella infections were UK- 
acquired, indicating that a travel history alone is an insufficient 
clinical indicator for Legionella disease. Classic atypical features 
were common, as was the well-recognised association with 
hyponatraemia, a greater degree of which was seen in those with 
neurological derangement. Only a few sputum samples were 
sent to a reference laboratory, limiting further epidemiological 
mapping of UK Legionella cases. There was high morbidity and 
mortality, with nearly one-third of patients requiring HDU or 
ITU care and over one-quarter dying, mainly within the first 
week of admission. Although generally poorly documented, in 
patients for whom a CURB-65 score was recorded, over half had 
a score of 0–2, which would indicate neither requesting of a 
Legionella test nor empirical LP treatment, according to current 
UK guidelines; therefore, LP cases might be being missed, 
untreated or both. 
Our study highlights the need for clinicians to consider a 
diagnosis of LP, be aware that travel history or low CURB-65 
score do not preclude the diagnosis, treat suspected LP early 
and appropriately and be vigilant in collection of samples for 
essential epidemiological profiling.
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